New

ERP Biomarker Consortium

The AI engine Fit Assessment

Beta

The company provides pharma-focused technology solutions centered on ERP biomarkers for CNS drug development, including automated measurement capabilities (e.g., the COGNISION System), standardized methods and SOPs, and formal qualification pathways, with active collaboration among major pharmaceutical companies to enable large-scale trials.

Blurb

The company operates and qualifys ERP Biomarkers for use in large-scale therapeutic CNS trials.

HQ Location

United States

Founded

Not available

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

EEG/ERP Biomarker Qualification Consortium (EBQC) aims to qualify, validate, and operationalize EEG/ERP biomarkers for use in CNS clinical trials. EBQC brings together a diverse group of stakeholders (industry, academic, regulatory) in the spirit of pre-competitive cooperation to ensure that robust and reliable EEG/ERP biomarkers can be implemented in clinical trials.